Literature DB >> 27255267

Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Martin J Brodie1, Frank Besag2, Alan B Ettinger2, Marco Mula2, Gabriella Gobbi2, Stefano Comai2, Albert P Aldenkamp2, Bernhard J Steinhoff2.   

Abstract

Antiepileptic drugs (AEDs) have many benefits but also many side effects, including aggression, agitation, and irritability, in some patients with epilepsy. This article offers a comprehensive summary of current understanding of aggressive behaviors in patients with epilepsy, including an evidence-based review of aggression during AED treatment. Aggression is seen in a minority of people with epilepsy. It is rarely seizure related but is interictal, sometimes occurring as part of complex psychiatric and behavioral comorbidities, and it is sometimes associated with AED treatment. We review the common neurotransmitter systems and brain regions implicated in both epilepsy and aggression, including the GABA, glutamate, serotonin, dopamine, and noradrenaline systems and the hippocampus, amygdala, prefrontal cortex, anterior cingulate cortex, and temporal lobes. Few controlled clinical studies have used behavioral measures to specifically examine aggression with AEDs, and most evidence comes from adverse event reporting from clinical and observational studies. A systematic approach was used to identify relevant publications, and we present a comprehensive, evidence-based summary of available data surrounding aggression-related behaviors with each of the currently available AEDs in both adults and in children/adolescents with epilepsy. A psychiatric history and history of a propensity toward aggression/anger should routinely be sought from patients, family members, and carers; its presence does not preclude the use of any specific AEDs, but those most likely to be implicated in these behaviors should be used with caution in such cases.
Copyright © 2016 The Author(s).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27255267      PMCID: PMC4931873          DOI: 10.1124/pr.115.012021

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  326 in total

Review 1.  The NMDA receptor complex as a therapeutic target in epilepsy: a review.

Authors:  Mehdi Ghasemi; Steven C Schachter
Journal:  Epilepsy Behav       Date:  2011-11-04       Impact factor: 2.937

Review 2.  Metabotropic glutamate receptors as drug targets: what's new?

Authors:  Ferdinando Nicoletti; Valeria Bruno; Richard Teke Ngomba; Roberto Gradini; Giuseppe Battaglia
Journal:  Curr Opin Pharmacol       Date:  2014-12-12       Impact factor: 5.547

Review 3.  Molecular biology of GABAA receptors.

Authors:  R W Olsen; A J Tobin
Journal:  FASEB J       Date:  1990-03       Impact factor: 5.191

4.  Positive and negative psychotropic effects of levetiracetam.

Authors:  C Helmstaedter; N E Fritz; E Kockelmann; N Kosanetzky; C E Elger
Journal:  Epilepsy Behav       Date:  2008-06-25       Impact factor: 2.937

5.  Hippocampal structural asymmetry in unsuccessful psychopaths.

Authors:  Adrian Raine; Sharon S Ishikawa; Estibaliz Arce; Todd Lencz; Kevin H Knuth; Susan Bihrle; Lori LaCasse; Patrick Colletti
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

6.  Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.

Authors:  Jan Volavka; Pal Czobor; Karen Nolan; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Thomas B Cooper; Jeffrey A Lieberman
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

Review 7.  The role of norepinephrine in epilepsy: from the bench to the bedside.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Francesca Biagioni; Luigi Murri; Francesco Fornai
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

Review 8.  Management of juvenile myoclonic epilepsy.

Authors:  Arielle Crespel; Philippe Gelisse; Ronald C Reed; Edoardo Ferlazzo; Judith Jerney; Bettina Schmitz; Pierre Genton
Journal:  Epilepsy Behav       Date:  2013-07       Impact factor: 2.937

9.  Gabapentin associated with aggressive behavior in pediatric patients with seizures.

Authors:  K B Tallian; M C Nahata; W Lo; C Y Tsao
Journal:  Epilepsia       Date:  1996-05       Impact factor: 5.864

10.  DNA methylation mediates persistent epileptiform activity in vitro and in vivo.

Authors:  Ziv M Machnes; Tony C T Huang; Philip K Y Chang; Raminder Gill; Nicholas Reist; Gabriella Dezsi; Ezgi Ozturk; Francois Charron; Terence J O'Brien; Nigel C Jones; R Anne McKinney; Moshe Szyf
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  37 in total

1.  The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity.

Authors:  Jin Wang; Jie Huang; Shan Yao; Jia-Hui Wu; Hui-Bin Li; Feng Gao; Ying Wang; Guo-Bin Huang; Qiang-Long You; Jianhua Li; Xiaohui Chen; Xiang-Dong Sun
Journal:  Cell Biosci       Date:  2021-05-21       Impact factor: 7.133

Review 2.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

3.  Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye.

Authors:  Atefeh Mousavi Nik; Brandon Pressly; Vikrant Singh; Shane Antrobus; Susan Hulsizer; Michael A Rogawski; Heike Wulff; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2017-04-20       Impact factor: 4.436

Review 4.  Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.

Authors:  Martin J Brodie
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

5.  Extending julius seizure, a bang-sensitive gene, as a model for studying epileptogenesis: Cold shock, and a new insertional mutation.

Authors:  Derek Dean; Hannah Weinstein; Seema Amin; Breelyn Karno; Emma McAvoy; Ronald Hoy; Andrew Recknagel; Casey Jarvis; David Deitcher
Journal:  Fly (Austin)       Date:  2017-12-08       Impact factor: 2.160

6.  SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.

Authors:  Lihong Shi; Miaomiao Zhu; Huilan Li; Zhipeng Wen; Xiaoping Chen; Jia Luo; Cong Lin; Zanling Zhang
Journal:  Eur J Clin Pharmacol       Date:  2019-01-28       Impact factor: 2.953

Review 7.  Epilepsy and Psychiatric Comorbidities: Drug Selection.

Authors:  Marco Mula
Journal:  Curr Treat Options Neurol       Date:  2017-10-19       Impact factor: 3.598

Review 8.  Tics induced by antiepileptic drugs: a pragmatic review.

Authors:  James Peters; Nirosen Vijiaratnam; Heather Angus-Leppan
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

9.  Association between epilepsy and psychiatric disorders in adults with intellectual disabilities: systematic review and meta-analysis.

Authors:  Basma Akrout Brizard; Bharati Limbu; Carolina Baeza-Velasco; Shoumitro Deb
Journal:  BJPsych Open       Date:  2021-05-03

10.  Agitation and Sugar Craving Related to Epilepsy Seizure.

Authors:  Rania Adel Hameed; Mohammad Reza F Aghdam
Journal:  Case Rep Psychiatry       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.